Pfizer Inc. (PFE) Downgraded to Hold by HSBC

Market Context

Pfizer Inc. operates in the Healthcare sector. The stock currently trades at $23.72 with a market capitalization of $146.7B. The stock has declined 3.6% over the past 52 weeks.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow HSBC's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Pfizer Inc.

Among the 10 most recent ratings: 2 Buy, 7 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Jul 06, 2026	Cantor Fitzgerald	Neutral	N/A
Jul 06, 2026	HSBC	Hold	N/A
Jun 10, 2026	RBC Capital	Sector Perform	N/A
Apr 29, 2026	Citigroup	Neutral	N/A
Apr 20, 2026	RBC Capital	Underperform	N/A

Related Tools: Analyst Ratings Dashboard | View PFE Stock Page